Concepedia

Anna P. Lam

AP

Statistics

Publications

5

Citations

443

H-Index

5

Active since

2001

Affiliations

University of Manchester(Current)

University of Toronto

Northwestern University

Massachusetts General Hospital

St. Vincent's University Hospital

Anna P. Lam is an author at University of Manchester specializing in cell biology, life sciences, and signal transduction.

Publications per year

2001–2025

5

Publications

5

Wnt/β‐catenin signaling is hyperactivated in systemic sclerosis and induces Smad‐dependent fibrotic responses in mesenchymal cells

Jun Wei, Feng Fang, Anna P. Lam et al. · Arthritis & Rheumatism · 2012 · 227 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials

Claire Keating, Lael M. Yonker, F. Vermeulen et al. · The Lancet Respiratory Medicine · 2025 · 89 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

Ahmet Uluer, Gordon MacGregor, Pilar Azevedo et al. · The Lancet Respiratory Medicine · 2023 · 64 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Failure of Bcl-2 to block mitochondrial dysfunction during TRAIL-induced apoptosis. Tumor necrosis-related apoptosis-inducing ligand.

Edward Kim, A Suliman, Anna P. Lam et al. · International Journal of Oncology · 2001 · 48 citations

Life Sciences, Cell Biology, Oncology +17

Cyclic stretch‐induced nuclear localization of transcription factors results in increased nuclear targeting of plasmids in alveolar epithelial cells

Anna P. Lam, David A. Dean · The Journal of Gene Medicine · 2008 · 15 citations

Life Sciences, Cell Biology, Molecular Biology +14

1–5 of 5